Skip to main content

Table 3 Treatment regimens

From: High rate of successful treatment outcomes among childhood rifampicin/multidrug-resistant tuberculosis in Pakistan: a multicentre retrospective observational analysis

Treatment regimen

No. (%)

Longer treatment regimen

198 (93.0)

 SLI + FQ + Eto + Cs + Z/FQ + Eto + Cs + Z

68 (31.9)

 SLI + FQ + Eto + Cs + PAS + Z/FQ + Eto + Cs + PAS + Z

55 (25.8)

 SLI + FQ + Eto + Cs + Z + E/FQ + Eto + Cs + Z + E

30 (14.1)

 SLI + FQ + Eto + Cs + PAS + Z + E/FQ + Eto + Cs + PAS + Z + E

10 (4.7)

 Othersa

35 (16.4)

Shorter treatment regimen

15 (7.0)

 Am + Z + FQ + Eto + Cfz + high dose H + E/Z + FQ + Cfz + E

15 (7.0)

  1. Cs cycloserine, E ethambutol, Eto ethionamide, FQ fluoroquinolones, Km kanamycin, PAS para-amino salicylic acid, SLI second-line injectable (amikacin/kanamycin/capreomycin), Z pyrazinamide
  2. aGiven in Additional file 1: Table S1